Screening for atrial fibrillation an evidence review for the U.S. Preventive Services Task Force
For treatment benefits and harms, we included trials of anticoagulation treatment for primary stroke prevention (warfarin or direct oral anticoagulants [DOACs]) compared with placebo or no treatment among persons with AF. Eligible outcomes included diagnostic yield, test accuracy, all-cause mortalit...
| Main Author: | |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Rockville, MD
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
January 2022, 2022
|
| Series: | Evidence synthesis
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references